Cargando…

385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?

BACKGROUND: Infection by SARS-CoV-2 can lead to dyspnea, edema, deposition of intra alveolar fibrin, thrombosis and hemorrhages. During the COVID-19. outbreak, several questions were raised about the risks for the pediatric population. Pediatric patients appeared to be relatively safe, with only min...

Descripción completa

Detalles Bibliográficos
Autores principales: Giarola, Lucca G, Couto, Braulio Roberto Gonçalves Marinho, Starling, Carlos Ernesto Ferreira, de Carvalho, Handerson Dias Duarte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777274/
http://dx.doi.org/10.1093/ofid/ofaa439.580
_version_ 1783630864586899456
author Giarola, Lucca G
Couto, Braulio Roberto Gonçalves Marinho
Starling, Carlos Ernesto Ferreira
de Carvalho, Handerson Dias Duarte
author_facet Giarola, Lucca G
Couto, Braulio Roberto Gonçalves Marinho
Starling, Carlos Ernesto Ferreira
de Carvalho, Handerson Dias Duarte
author_sort Giarola, Lucca G
collection PubMed
description BACKGROUND: Infection by SARS-CoV-2 can lead to dyspnea, edema, deposition of intra alveolar fibrin, thrombosis and hemorrhages. During the COVID-19. outbreak, several questions were raised about the risks for the pediatric population. Pediatric patients appeared to be relatively safe, with only minor symptoms and a quick recovery. However, there have been reports of a relationship between COVID 19 and a Kawasaki-like inflammatory disease in this population. Kawasaki’s disease (KD) is a rheumatological vasculitis prevalent in childhood characterized mainly by diffuse inflammation of the arteries associated with skin rash, changes in the mucosa and its main complication is coronary aneurysms. METHODS: A systematic literature review was performed in the PubMED database using the keywords “Kawasaki disease”, “COVID-19” and “Pediatrics”. The selected filters were “Case reports”, “Multicenter study”, “Clinical Study”, “Observational study”, “Human” and “English”. A total of 18 articles were seleted. RESULTS: There seems to be a convergence between the literature published so far, pointing to a greater propensity for pediatric patients infected with Sars-Cov-2 to develop KD. The number of patients with KD symptoms seen at a specific center increased from 2 to 17 in 11 days (MOREIRA, 2020). In a sample space of 21 patients diagnosed with KD, 91% had previous contact with SARS-CoV-2 (TOUBIANA, 2020) whereas other studies point to a 30-fold increase in the prevalence of KD since the beginning of 2020 (VERDONI, 2020). There is already an established relationship between DK and HCoV-NH, describing that 4.5% of patients with this infection develop KD. Therefore, it was suggested that infection with another Coronavirus strain could have a similar relationship. CONCLUSION: Despite the relationship described between pediatric patients infected with COVID-19 being more likely to develop KD, further studies are needed to prove a statistical relationship between both condition. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777274
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77772742021-01-07 385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis? Giarola, Lucca G Couto, Braulio Roberto Gonçalves Marinho Starling, Carlos Ernesto Ferreira de Carvalho, Handerson Dias Duarte Open Forum Infect Dis Poster Abstracts BACKGROUND: Infection by SARS-CoV-2 can lead to dyspnea, edema, deposition of intra alveolar fibrin, thrombosis and hemorrhages. During the COVID-19. outbreak, several questions were raised about the risks for the pediatric population. Pediatric patients appeared to be relatively safe, with only minor symptoms and a quick recovery. However, there have been reports of a relationship between COVID 19 and a Kawasaki-like inflammatory disease in this population. Kawasaki’s disease (KD) is a rheumatological vasculitis prevalent in childhood characterized mainly by diffuse inflammation of the arteries associated with skin rash, changes in the mucosa and its main complication is coronary aneurysms. METHODS: A systematic literature review was performed in the PubMED database using the keywords “Kawasaki disease”, “COVID-19” and “Pediatrics”. The selected filters were “Case reports”, “Multicenter study”, “Clinical Study”, “Observational study”, “Human” and “English”. A total of 18 articles were seleted. RESULTS: There seems to be a convergence between the literature published so far, pointing to a greater propensity for pediatric patients infected with Sars-Cov-2 to develop KD. The number of patients with KD symptoms seen at a specific center increased from 2 to 17 in 11 days (MOREIRA, 2020). In a sample space of 21 patients diagnosed with KD, 91% had previous contact with SARS-CoV-2 (TOUBIANA, 2020) whereas other studies point to a 30-fold increase in the prevalence of KD since the beginning of 2020 (VERDONI, 2020). There is already an established relationship between DK and HCoV-NH, describing that 4.5% of patients with this infection develop KD. Therefore, it was suggested that infection with another Coronavirus strain could have a similar relationship. CONCLUSION: Despite the relationship described between pediatric patients infected with COVID-19 being more likely to develop KD, further studies are needed to prove a statistical relationship between both condition. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777274/ http://dx.doi.org/10.1093/ofid/ofaa439.580 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Giarola, Lucca G
Couto, Braulio Roberto Gonçalves Marinho
Starling, Carlos Ernesto Ferreira
de Carvalho, Handerson Dias Duarte
385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
title 385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
title_full 385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
title_fullStr 385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
title_full_unstemmed 385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
title_short 385. Kawasaki’s Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
title_sort 385. kawasaki’s disease and sars-cov-2: an unexpected pediatric global crisis?
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777274/
http://dx.doi.org/10.1093/ofid/ofaa439.580
work_keys_str_mv AT giarolaluccag 385kawasakisdiseaseandsarscov2anunexpectedpediatricglobalcrisis
AT coutobrauliorobertogoncalvesmarinho 385kawasakisdiseaseandsarscov2anunexpectedpediatricglobalcrisis
AT starlingcarlosernestoferreira 385kawasakisdiseaseandsarscov2anunexpectedpediatricglobalcrisis
AT decarvalhohandersondiasduarte 385kawasakisdiseaseandsarscov2anunexpectedpediatricglobalcrisis